7 Optimising Prevention of Pneumococcal Disease With Pneumococcal Conjugate Vaccines Pfizer Symposium, 23 October 2010, 13:00-14:00

Pediatric Research - United States
doi 10.1203/00006450-201011001-00007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Meeting the Challenge: Prevention of Pneumococcal Disease With Conjugate Vaccines

Salud Publica de Mexico
EnvironmentalPublic HealthOccupational Health
2001English

Pneumococcal Conjugate Vaccines in Different Settings

The Lancet Infectious Diseases
Infectious Diseases
2019English

Pneumococcal Conjugate Vaccines: New Hope for Infancy

Revista Chilena de Infectologia
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2001English

The Impact of 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review

Advances in Therapy
MedicinePharmacology
2013English

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

Pneumococcal Conjugate Vaccines in Different Settings – Authors' Reply

The Lancet Infectious Diseases
Infectious Diseases
2019English

The Duopoly of Ten-Valent and 13-Valent Pneumococcal Conjugate Vaccines: Do They Differ?

The Lancet Infectious Diseases
Infectious Diseases
2019English

New Vaccines for Prevention of Pneumococcal Infections

Annals of Medicine
Medicine
1995English

Effects of Supplemental Lighting From 23:00 to 7:00 on Growth of Vegetables Cultured by NFT.

Engei Gakkai zasshi
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy